CHU Besançon

Besançon 25030

4 studies enrolling now · 7 studies all time

What they study most

Bladder Carcinoma, Breast Neoplasms, Cutaneous Melanoma, Endometrial Carcinoma, Epithelial Ovarian Carcinoma, Esophageal Carcinoma, Fallopian Tube Carcinoma, Fallopian Tube Neoplasms, Gastric Adenocarcinoma, Gastroesophageal Junction Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Carcinoma

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — Recruiting now
• A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer — Running, not enrolling
• Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers — Running, not enrolling
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed